Cloning and expression of autogenes encoding RNA poly,erases of T7-like bacteriophages

• US 5,824,528 A
• Filed: 08/15/1994
• Issued: 10/20/1998
• Est. Priority Date: 05/01/1992
• Status: Expired due to Fees

• Current Assignee: Brookhaven Science Associates, LLC (Government of the United States of America)
• Original Assignee: Associated Universities, Inc.
• Inventors: Dubendorff, John W., Studier, F. William
• Primary Examiner(s): Fleisher, Mindy
• Assistant Examiner(s): ELLIOTT, GEORGE C
• Application Number:
  US08/292,081
• Time in Patent Office: 1,527 Days
• Field of Search: 536/23.2, 536/23.72, 435/232, 435/320.1, 435/194, 435/252.3, 435/252.33
• US Class Current: 435/194
• CPC Class Codes: C12N 9/1247 DNA-directed RNA polymerase (2.7.7.6)

Abstract

This invention relates to the cloning and expression of autogenes encoding RNA polymerases of T7 and T7-like bacteriophages, in which the RNA polymerase gene is transcribed from a promoter which is recognized by the encoded RNA polymerase. Cloning of T7 autogenes was achieved by reducing the activity of the RNA polymerase sufficiently to permit host cell growth. T7 RNA polymerase activity was controlled by combining two independent methods: lac-repression of the recombinant lac operator-T7 promoter in the autogene and inhibition of the polymerase by T7 lysozyme. Expression systems for producing the RNA polymerases of T7 and other T7-like bacteriophages, and expression systems for producing selected gene products are described, as well as other related materials and methods.

Claims

1. An autogene, comprising a gene encoding a T7-like bacteriophage RNA polymerase under the control of an autogene promoter recognized by said polymerase.

3. The autogene of claim 1, wherein said bacteriophage is selected from the group consisting of:

a) Escherichia coli phages T7, T3, φ

I, φ

II, W31, H, Y, A1122, cro, C21, C22, and C23;

b) Pseudomonas putida phage gh-1;

c) Salmonella typhimurium phage SP6;

d) Serratia marcescens phage IV;

e) Citrobacter phage ViIII; and

f) Klebsiella phage Number 11.

4. The autogene of claim 1, wherein the autogene promoter is selected from the group consisting of:

a) a naturally occurring bacteriophage promoter; and

b) a naturally occurring bacteriophage promoter having an alteration which changes the strength of the promoter relative to that of the wild type promoter, but is still recognized by said polymerase.

7. The autogene of claim 1, wherein the autogene promoter is regulatable and comprises:

a) a promoter which is recognized by the autogene-encoded RNA polymerase; and

b) the binding site of a DNA-binding protein;

wherein binding of said DNA-binding protein interferes with transcription from said autogene promoter.

8. The autogene of claim 7, wherein the binding site is the lac operator.

9. The autogene of claim 8, wherein the autogene promoter is recognized by T7 RNA polymerase and the lac operator is centered at a position from +12 to +21 relative to the transcriptional start site.

10. The autogene of claim 9, wherein the autogene promoter comprises a sequence selected from the group consisting of:

a) TAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCC (Seq. ID #27;

nucleotides 1-44 of Seq. ID #6);

b) TAATACGACTCACTATAGGGGAATTGTTATCCGCTCACAATTCC (Seq. ID #28;

nucleotides 1-44 of Seq. ID #7);

c) TAATACGACTCACTATAGGGAATTGTGAGCGGATAACAATTCC (Seq. ID #10);

d) TAATACGACTCACTATAGGGAATTGTTATCCGCTCACAATTCC (Seq. ID #11);

e) TAATACGACTCACTATAGGAATTGTGAGCGGATAACAATTCC (Seq. ID #12);

f) TAATACGACTCACTATAGGAATTGTTATCCGCTCACAATTCC (Seq. ID #13);

g) TAATACGACTCACTATAGAATTGTGAGCGGATAACAATTC (Seq. ID #

     14);

h) TAATACGACTCACTATAGAATTGTTATCCGCTCACAATTC (Seq. ID #15); and

i) TAATACGACTCACTATAGGGAGAGGGGAATTGTGAGCGGATAACA ATTCC (Seq. ID #29;

nucleotides 1-50 of Seq. ID #8).

2. An autogene, comprising a gene encoding bacteriophage T7 RNA polymerase under the control of an autogene promoter recognized by said polymerase.

5. The autogene of claim 2, wherein the autogene promoter recognized by T7 RNA polymerase is selected from the group consisting of:

a) a naturally occurring class III promoter;

b) a naturally occurring class II promoter; and

c) a naturally occurring T7 promoter having an alteration in the -17 to +6 region.

6. The autogene of claim 5, wherein the autogene promoter is the T7 φ

10 promoter whose DNA sequence differs from natural T7 class III promoters by containing AG instead of GA at positions +4 and +5, where +1 is the transcriptional start site.

11. A construct for expressing the RNA polymerase of a T7-like bacteriophage, comprising:

a) an autogene, which comprises a gene encoding a T7-like bacteriophage RNA polymerase under the control of an autogene promoter recognized by said polymerase; and

b) a vector appropriate for maintenance of the construct in a host cell.

12. The construct of claim 11, wherein the T7-like bacteriophage is selected from the group consisting of:

a) Escherichia coli phages T7, T3, φ

I, φ

II, W31, H, Y, A1122, cro, C21, C22, and C23;

b) Pseudomonas putida phage gh-1;

c) Salmonella typhimurium phage SP6;

d) Serratia marcescens phage IV;

e) Citrobacter phage ViIII; and

f) Klebsiella phage Number 11.

13. The construct of claim 11, wherein the autogene promoter is regulatable and comprises:

a) a promoter which is recognized by the autogene-encoded RNA polymerase; and

b) the binding site of a DNA-binding protein;

wherein binding of said DNA-binding protein interferes with transcription from said autogene promoter.

14. The construct of claim 13, wherein the autogene promoter is recognized by T7 RNA polymerase and the binding site is the lac operator, wherein the lac operator is centered at a position from +12 to +21 relative to the transcriptional start site.

15. The construct of claim 13, further comprising a sequence selected from the group consisting of:

a) a lacI gene under the control of a second promoter;

b) the T7 transcriptional terminator Tφ

placed downstream of the autogene; and

c) combinations of these.

16. The construct of claim 15, wherein the second promoter is the natural promoter of the lacI gene.

17. The construct of claim 15, wherein the lacI gene is transcribed in the opposite direction from the autogene.

18. The construct of claim 15, which is selected from the group consisting of:

a) pT7AUTO-1;

b) pT7AUTO-2;

c) pT7AUTO-3; and

d) pT7AUTO-4.

19. An expression system for producing T7 RNA polymerase in host cells, comprising:

a) an autogene construct, comprising;

1) an autogene, which comprises a gene encoding T7 RNA polymerase under the control of an autogene promoter comprising;

a) a promoter recognized by said polymerase; and

b) the lac operator, wherein the lac operator is centered at a position from +12 to +21 relative to the transcriptional start site; and

2) the lacI gene under the control of a second promoter; and

b) a lysozyme construct, comprising a T7 lysozyme gene under the control of a third promoter.

20. The system of claim 19, wherein the autogene and lysozyme constructs, respectively, are selected from the group consisting of:

a) pT7AUTO-1 and pLysL;

b) pT7AUTO-2 and pLysS;

c) pT7AUTO-1 and pLysS;

d) pT7AUTO-2 and pLysE;

e) pT7AUTO-3 and pLysE;

f) pT7AUTO-1 and pLysE;

g) pT7AUTO-1 and pLysH; and

h) pT7AUTO-2 and pLysH.

21. A method for producing T7 RNA polymerase in host cells, comprising the steps of:

a) providing host cells;

b) providing the expression system of claim 19;

c) introducing the expression system into the host cells, thereby producing host cells containing the expression system; and

d) inducing expression of the autogene, thereby producing host cells expressing T7 RNA polymerase;

thereby producing T7 RNA polymerase.

22. The method of claim 21, wherein the autogene and lysozyme constructs, respectively, are selected from the group consisting of:

a) pT7AUTO-1 and pLysL;

b) pT7AUTO-2 and pLysS;

c) pT7AUTO-1 and pLysS;

d) pT7AUTO-2 and pLysE;

e) pT7AUTO-3 and pLysE;

f) pT7AUTO-1 and pLysE;

g) pT7AUTO-1 and pLysH; and

h) pT7AUTO-2 and pLysH.

23. The host cells obtained in step c) of claim 21.

24. The method of claim 21, further comprising isolating the T7 RNA polymerase from the host cells produced in step d).

25. A method for producing an autogene, comprising:

a) providing a first DNA fragment that contains the complete coding sequence for the RNA polymerase of a T7-like bacteriophage but no promoter that is recognized by said RNA polymerase;

b) providing a second DNA fragment that contains a promoter that is recognized by said bacteriophage RNA polymerase; and

c) joining said first and second DNA fragments so as to place the coding sequence for said bacteriophage RNA polymerase under control of said promoter that is recognized by said bacteriophage RNA polymerase, producing an autogene.

26. The method of claim 25, wherein said bacteriophage is selected from the group consisting of:

(a) Escherichia coli phages T7, T3, φ

I, φ

II, W31, H, Y, A1122, cro, C21, C22, and C23;

(b) Pseudomonas putida phage gh-1;

(c) Salmonella typhimurium phage SP6;

(d) Serratia marcescens phage IV;

(e) Citrobacter phage ViIII; and

(f) Klebsiella phage Number 11.

27. The method of claim 25, wherein the autogene promoter is selected from the group consisting of:

(a) a naturally occurring bacteriophage promoter; and

(b) a naturally occurring bacteriophage promoter having an alteration which changes the strength of the promoter relative to that of the wild type promoter, but is still recognized by said polymerase.

28. The method of claim 25, wherein the bacteriophage is T7 and the autogene promoter recognized by T7 RNA polymerase is selected from the group consisting of:

(a) a naturally occurring class III promoter;

(b) a naturally occurring class II promoter; and

(c) a naturally occurring T7 promoter having an alteration in the -17 to +6 region.

29. The method of claim 25, wherein the method further comprises:

providing a third DNA fragment encoding a binding site of a DNA-binding protein; and

inserting the binding site into the autogene such that binding of the DNA-binding protein to the binding site interferes with transcription from said autogene promoter.

30. The method of claim 25, wherein the method further comprises modifying the first DNA fragment so as to change the efficiency of translation of the coding sequence for the RNA polymerase in a host cell.

31. An autogene produced by the method of claim 30, wherein the efficiency of translation of the coding sequence for the RNA polymerase in a host cell is decreased.

32. An autogene produced by the method of claim 30, wherein the efficiency of translation of the coding sequence for the RNA polymerase in a host cell is increased.